Trial Profile
Pilot Study of the Effect of Duavee on Benign Breast Tissue Proliferation in Peri or Post-menopausal Women at Moderate Risk for Development of Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2022
Price :
$35
*
At a glance
- Drugs Conjugated estrogens/bazedoxifene (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 08 Mar 2022 Status changed from active, no longer recruiting to completed.
- 14 Dec 2019 Results , assessing the feasibility and effects on biomarkers of conjugated-estrogens/bazedoxifene in peri- and post-menopausal women at moderate risk for development of breast cancer, presented at the 42nd Annual San Antonio Breast Cancer Symposium
- 04 Feb 2019 Planned End Date changed from 1 May 2019 to 1 Jun 2019.